Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cellebrite DI (CLBT) Amortization - Deferred Charges: 2023-2024

Historic Amortization - Deferred Charges for Cellebrite DI (CLBT) over the last 2 years, with Dec 2024 value amounting to $670.0 million.

  • Cellebrite DI's Amortization - Deferred Charges rose 252.13% to $670.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $332.9 million, marking a year-over-year increase of 205.97%. This contributed to the annual value of $332.9 million for FY2024, which is 205.97% up from last year.
  • Latest data reveals that Cellebrite DI reported Amortization - Deferred Charges of $670.0 million as of Q4 2024, which was up 399.11% from -$224.0 million recorded in Q3 2024.
  • Cellebrite DI's 5-year Amortization - Deferred Charges high stood at $670.0 million for Q4 2024, and its period low was -$224.0 million during Q3 2024.
  • Moreover, its 2-year median value for Amortization - Deferred Charges was -$35.3 million (2023), whereas its average is $55.2 million.
  • Within the past 5 years, the most significant YoY rise in Cellebrite DI's Amortization - Deferred Charges was 252.13% (2024), while the steepest drop was 3,278.31% (2024).
  • Quarterly analysis of 2 years shows Cellebrite DI's Amortization - Deferred Charges stood at $190.3 million in 2023, then surged by 252.13% to $670.0 million in 2024.
  • Its Amortization - Deferred Charges stands at $670.0 million for Q4 2024, versus -$224.0 million for Q3 2024 and -$34.5 million for Q2 2024.